Engineering Papers⌕ Search

SEARCH · Engineering Papers

Results for “infusion”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 127 records · Page 7

Using Existing NASA Satellites as Orbiting Testbeds to Accelerate Technology Infusion into Future Missions

One of the shared problems for new space mission developers is that it is extremely difficult to infuse new technology into new missions unless that technology has been flight validated. Therefore, the issue is that new technology is required to fly on a successful mission for flight validation. We have been experimenting with new technology on existing satellites by retrofitting primarily the flight software while the missions are on-orbit to experiment with new operations concepts. Experiments have been using Earth Observing 1 (EO-1), which is part of the New Millennium Program at NASA. EO-1 finished its prime mission one year after its launch on November 21,2000. From November 21,2001 until the present, EO-1 has been used in parallel with additional science data gathering to test out various sensor web concepts. Similarly, the Cosmic Hot Interstellar Plasma Spectrometer (CHIPS) satellite was also a one year mission flown by the University of Berkeley, sponsored by NASA and whose prime mission ended August 30,2005. Presently, CHIPS is being used to experiment with a seamless space to ground interface by installing Core Flight System (cFS), a "plug-and-play" architecture developed by the Flight Software Branch at NASA/GSFC on top of the existing space-to-ground Internet Protocol (IP) interface that CHIPS implemented. For example, one targeted experiment is to connect CHIPS to a rover via this interface and the Internet, and trigger autonomous actions on CHIPS, the rover or both. Thus far, having satellites to experiment with new concepts has turned out to be an inexpensive way to infuse new technology for future missions. Relevant experiences thus far and future plans will be discussed in this presentation.

Mandl, Daniel↗

Technology Transition a Model for Infusion and Commercialization

The National Aeronautics and Space Administration has as part of its charter the mission of transferring technologies developed for the space program into the private sector for the purpose of affording back to the American people the economical and improved quality of life benefits associated with the technologies developed. In recent years considerable effort has been made to use this program for not only transitioning technologies out of the NASA Mission Directorate Programs, but also to transfer technologies into the Mission Directorate Programs and leverage the impact of government and private sector innovation. The objective of this paper is to outline an approach and the creation of a model that brings together industry, government, and commercialization strategies. When these elements are integrated, the probability of successful technology development, technology infusion into the Mission Programs, and commercialization into the private sector is increased. This model primarily addresses technology readiness levels between TRL 3 and TRL 6. This is typically a gap area known as the valley of death. This gap area is too low for commercial entities to invest heavily and not developed enough for major programs to actively pursue. This model has shown promise for increasing the probably of TRL advancement to an acceptable level for NASA programs and/or commercial entities to afford large investments toward either commercialization or infusion.

McMillan, Vernotto C.↗

Resin film infusion mold tooling and molding method

A mold apparatus and method for resin film infusion molding including an outer mold tool having a facing sheet adapted to support a resin film and preform assembly. The facing sheet includes attachment features extending therefrom. An inner mold tool is positioned on the facing sheet to enclose the resin film and preform assembly for resin film infusion molding. The inner mold tool includes a plurality of mandrels positioned for engagement with the resin film and preform assembly. Each mandrel includes a slot formed therein. A plurality of locating bars cooperate with the slots and with the attachment features for locating the mandrels longitudinally on the outer mold tool.

Burgess, Roger↗

Process Optimization of Bismaleimide (BMI) Resin Infused Carbon Fiber Composite

Bismaleimide (BMI) resins are an attractive new addition to world-wide composite applications. This type of thermosetting polyimide provides several unique characteristics such as excellent physical property retention at elevated temperatures and in wet environments, constant electrical properties over a vast array of temperature settings, and nonflammability properties as well. This makes BMI a popular choice in advance composites and electronics applications [I]. Bismaleimide-2 (BMI-2) resin was used to infuse intermediate modulus 7 (IM7) based carbon fiber. Two panel configurations consisting of 4 plies with [+45deg, 90deg]2 and [0deg]4 orientations were fabricated. For tensile testing, a [90deg]4 configuration was tested by rotating the [0deg]4 configirration to lie orthogonal with the load direction of the test fixture. Curing of the BMI-2/IM7 system utilized an optimal infusion process which focused on the integration of the manufacturer-recommended ramp rates,. hold times, and cure temperatures. Completion of the cure cycle for the BMI-2/IM7 composite yielded a product with multiple surface voids determined through visual and metallographic observation. Although the curing cycle was the same for the three panellayups, the surface voids that remained within the material post-cure were different in abundance, shape, and size. For tensile testing, the [0deg]4 layup had a 19.9% and 21.7% greater average tensile strain performance compared to the [90deg]4 and [+45deg, 90deg, 90deg,-45degg] layups, respectively, at failure. For tensile stress performance, the [0deg]4 layup had a 5.8% and 34.0% greater average performance% than the [90deg]4 and [+45deg, 90deg, 90deg,-45deg] layups.

Ehrlich, Joshua W.↗

Green Propellant Infusion Mission Program Development and Technology Maturation

The NASA Space Technology Mission Directorate's (STMD) Green Propellant Infusion Mission (GPIM) Technology Demonstration Mission (TDM) is comprised of a cross-cutting team of domestic spacecraft propulsion and storable green propellant technology experts. This TDM is led by Ball Aerospace & Technologies Corp. (BATC), who will use their BCP- 100 spacecraft to carry a propulsion system payload consisting of one 22 N thruster for primary divert (DeltaV) maneuvers and four 1 N thrusters for attitude control, in a flight demonstration of the AF-M315E technology. The GPIM project has technology infusion team members from all three major market sectors: Industry, NASA, and the Department of Defense (DoD). The GPIM project team includes BATC, includes Aerojet Rocketdyne (AR), Air Force Research Laboratory, Aerospace Systems Directorate, Edwards AFB (AFRL), NASA Glenn Research Center (GRC), NASA Kennedy Space Center (KSC), and NASA Goddard Space Flight Center (GSFC). STMD programmatic and technology oversight is provided by NASA Marshall Space Flight Center. The GPIM project shall fly an operational AF-M315E green propulsion subsystem on a Ball-built BCP-100 spacecraft.

AF-M315E↗

Infusing Stretch Goal Requirements into the Constellation Program

In 2004, the Vision for Space Exploration (VSE) was announced by the United States President's Administration in an effort to explore space and to extend a human presence across our solar system. Subsequently, the National Aeronautics and Space Administration (NASA) established the Exploration Systems Mission Directorate (ESMD) to develop a constellation of new capabilities, supporting technologies, and foundational research that allows for the sustained and affordable exploration of space. Then, ESMD specified the primary mission for the Constellation Program to carry out a series of human expeditions, ranging from Low Earth Orbit (LEO) to the surface of Moon, Mars, and beyond for the purposes of conducting human exploration of space. Thus, the Constellation Program was established at the Lyndon B. Johnson Space Center (JSC) to manage the development of the flight and ground infrastructure and systems that can enable continued and extended human access to space. Constellation Program's "Design Objectives" call for an early attention to the program's life cycle costs management through the Program's Need, Goals, and Objectives (NGO) document, which provides the vision, scope, and key areas of focus for the Program. One general policy of the Constellation Program, found in the Constellation Architecture Requirements Document (CARD), states: "A sustainable program hinges on how effectively total life cycle costs are managed. Developmental costs are a key consideration, but total life cycle costs related to the production, processing, and operation of the entire architecture must be accounted for in design decisions sufficiently to ensure future resources are available for ever more ambitious missions into the solar system....It is the intent of the Constellation Program to aggressively manage this aspect of the program using the design policies and simplicity." To respond to the Program's strong desire to manage the program life cycle costs, special efforts were established to identify operability requirements to influence flight vehicle and ground infrastructure design in order to impact the life cycle operations costs, and stretch goal requirements were introduced to the Program. This paper will describe how these stretch goal requirements were identified, developed, refined, matured, approved, and infused into the CARD. The paper will also document several challenges encountered when infusing the stretch goal requirements into the Constellation Program.

Operability↗

A Benefit Analysis of Infusing Wireless into Aircraft and Fleet Operations - Report to Seedling Project Efficient Reconfigurable Cockpit Design and Fleet Operations Using Software Intensive, Network Enabled, Wireless Architecture (ECON)

We report on an examination of potential benefits of infusing wireless technologies into various areas of aircraft and airspace operations. The analysis is done in support of a NASA seedling project Efficient Reconfigurable Cockpit Design and Fleet Operations Using Software Intensive, Network Enabled Wireless Architecture (ECON). The study has two objectives. First, we investigate one of the main benefit hypotheses of the ECON proposal: that the replacement of wired technologies with wireless would lead to significant weight reductions on an aircraft, among other benefits. Second, we advance a list of wireless technology applications and discuss their system benefits. With regard to the primary hypothesis, we conclude that the promise of weight reduction is premature. Specificity of the system domain and aircraft, criticality of components, reliability of wireless technologies, the weight of replacement or augmentation equipment, and the cost of infusion must all be taken into account among other considerations, to produce a reliable estimate of weight savings or increase.

Alexandrov, Natalia↗

Green Propulsion Advancement and Infusion

All space missions benefit from increased propulsion system performance, allowing lower spacecraft launch mass, larger scientific payloads, or extended on-orbit lifetimes. Likewise, long-term storable liquid propellant candidates that offer significant reduction in personnel hazards and shorter payload processing schedules present a more attractive propulsion subsystem solution to spacecraft builders. Aiming to reduce risk to potential infusion missions and fully comprehend the alternative propellant performance, the work presented herein represents many years of development and collaborative efforts to successfully align higher performance, low toxicity green propellants into NASA Goddard Space Flight Center (GSFC) missions. High Performance Green Propulsion (HPGP), and the associated propellant technology, has advanced significantly in maturity with increased familiarity with LMP-103S propellant handling, the proven reduction in loading hazards, successful launches conducted at multiple international Ranges, and HPGP on-orbit flight heritage. As science missions move forward to the potential infusion of HPGP technology, the National Aeronautics and Space Administration (NASA) and its partners are working to address gaps in system performance and operational considerations.

Spacecraft Propulsion and Power↗

A Decade of NASA Strategic Astrophysics Technology Investments: Technology Maturation, Infusion, and Other Benefits

NASA’s Astrophysics Division (APD) funds development of cutting-edge technology to enable its missions to achieve ambitious and groundbreaking science goals. These technology development efforts are managed by the Physics of the Cosmos (PCOS), Cosmic Origins (COR), and Exoplanet Exploration (ExE) Programs. The NASA Strategic Astrophysics Technology (SAT) Program was established in 2009 as a new technology maturation program to fill the gap in the Technology Readiness Level (TRL) range from 3 to 6. Since program inception, 100 SAT grants have been openly competed and awarded, along with dozens of direct-funded projects, leading to a host of technologies advancing their TRLs and/or being infused into space and suborbital missions and ground-based projects. We present the portfolio distribution in terms of specific technology areas addressed, including optics, detectors, coatings, coronagraphs, starshades, lasers, electronics, cooling systems, and micro-thruster subsystems. We show an analysis of the rate of TRL advances, infusion success stories, and other benefits such as training the future astrophysics workforce, including students and postdoctoral fellows hired by projects. Finally, we present APD’s current strategic technology maturation priorities for investment, enabling a range of future strategic astrophysics missions

NASA, astrophysics, technology development, optics↗

Infusing software assurance research techniques into use

Research in the software engineering community continues to lead to new development techniques that encompass processes, methods and tools. However, a number of obstacles impede their infusion into software deveopment practices. This paper describes an ongoing effort conducted by a software engineering research infusion team established by NASA's Software Engineering Intiative to overcome these obstacles.

Trevino, Luis C.↗

Infusion of Autonomy Technology into Space Missions: DS1 Lessons Learned

The impact of infusing breakthrough autonomy technology into a flight project was a big surprise. Valuable technical and cultural lessons, many of general applicability when intorducing system-level autonomy, have been learned by infusing the Remote Agent (RA) into NASA's Deep Space 1 (DS1) Spacecraft.

Autonomy↗

Technology Infusion in U.S. Spacesuits - A Comparative System Analysis

The National Aeronautics and Space Administration (NASA) has evolved multiple spacesuit systems for performing extravehicular activity (EVA) or space walks. These spacesuit systems include the Apollo Extravehicular Mobility Unit (EMU), Space Shuttle and International Space Station (ISS) EMU, and Exploration EMU (xEMU). Each spacesuit system is like the other for functionality. However, each spacesuit system is different in configuration based on the technology infused into the system associated with the purpose of the mission. Each spacesuit system is made up of many components and the integrate environment targeted for operations leads to an integrated system that is complex. Since Apollo, NASA has invested in multiple technologies that make up these spacesuit systems in different iterations. The Apollo EMU was designed in the 1960’s with a focus to facilitate the first human to walk on the moon. The Space Shuttle EMU was designed in the 1970’s for reusable microgravity operations that began in the early 1980’s. The Space Shuttle EMU was enhanced to facilitate extended operation on the ISS. Over the last 15 years, NASA has been designing, developing, and testing a new spacesuit system, the xEMU which is considered a design, verification, and test unit. NASA is planning to land the first woman and first person of color on the Moon. NASA recently engaged industry through a new contractual arrangement to provide EVA services needed to return to the Moon and to continue operations on the ISS. Spacesuit systems are complex. Understanding the requirements, operational environment, the necessary technologies, and the integrated spacesuit system are paramount. In addition, understanding the technology infusion process to meet the mission objectives is critical. This paper will review the spacesuit systems for EVA and several component functions within the spacesuits, along with a system comparison of those technologies from Apollo to xEMU.

Extravehicular Activity (EVA)↗

Hydrogen infused nuclear reactor core monoliths

Hydrogen infused nuclear reactor core monoliths and processes for their production are disclosed. Such monoliths may function as both a core monolith and a moderator, providing structure and at least some moderation. Hydrogen infused monoliths may be complementary to or be used in lieu of separate moderators for thermalizing neutrons.

Shivprasad, Aditya↗

Infusible acrylic thermoplastic resins: Tailoring of chemorheological properties

Infusible liquid resins that polymerize into a thermoplastic are desirable for many applications. Similar to unsaturated and vinylester thermosetting systems, they consist of polymers dissolved in reactive monomer. This work presents a method to decrease cycle time by tuning the molecular weight and concentration of the predissolved polymer in the resin. Variation of these properties allows precise control of the viscosity which in turn controls the time at which peak exotherm is reached, the maximum temperature for a given part thickness, and cure time. In this work, predictive models for the viscosity dependence on molecular weight, polymer concentration, shear rate, and temperature are developed. Two fiberglass panels are fabricated and tested; one with a lower molecular weight ($M_w$~30 kg mol –1 ) poly(methyl methacrylate) dissolved in methyl methacrylate and the second with higher molecular weight ($M_w$~500 kg mol –1 ) predissolved polymer in the resin. Mechanical properties are indistinguishable but the lower molecular weight panel cures up to three times faster.

36 MATERIALS SCIENCE↗

Transcatheter arterial infusion for pancreatic cancer: a 10-year National Cancer Center experience in 115 patients and literature review

Purpose: To evaluate the efficacy and safety of transcatheter arterial infusion (TAI) for the treatment of pancreatic cancer in patients ineligible for or refractory to systemic chemotherapy. Materials and methods: The medical records of 115 consecutive patients (mean age, 58.9 years; 71 males) with documented pancreatic cancer ineligible for or refractory to systemic chemotherapy and underwent TAI between February 2007 and January 2017 were reviewed. Results: A total of 224 TAI sessions [mean, 1.9 (range 1–8)] were performed. Technical success rate was 100%. Disease control (i.e., complete response, partial response, and stable disease) was achieved in 72 (62.6%) patients. The median progression-free survival and median overall survival were 56 days and 147 days, respectively. Subgroup analysis revealed that disease control, progression-free survival, and overall survival were significantly improved in patients with an Eastern Cooperative Oncology Group score of ≤ 1 compared with those in patients with an Eastern Cooperative Oncology Group score of 2 (all p < 0.001) and in patients who received > 1 sessions of TAI compared with that in patients who received only 1 session of TAI (p = 0.012, < 0.001, and = 0.002, respectively). A major complication in the form of cerebral infarction occurred in 1 (0.9%) patient 1 day after the procedure. This patient was treated with conservative therapy and recovered without permanent adverse sequelae. No other major complications were observed. Conclusions: TAI may be effective and safe for the treatment of pancreatic cancer.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Early Detection of Therapeutic Response to Hepatic Arterial Infusion Chemotherapy of Liver Metastases from Colorectal Cancer Using Diffusion-Weighted MR Imaging

The purpose of this study was to investigate whether diffusion-weighted magnetic resonance imaging (DWI) is useful for early detection of the response of hepatic colorectal metastases to hepatic arterial infusion chemotherapy (HAIC) with 5-fluorouracil (5-FU). The subjects were 12 patients with hepatic colorectal metastases. The indwelling catheter for HAIC was placed in the hepatic artery, and 1000 mg/m{sup 2} 5-FU was given repeatedly once a week. DWI was performed before and 9 days after HAIC. The minimum and mean apparent diffusion coefficient (ADC) values (minADC and meanADC) were measured. The relative change in ADC values (%ADC) and the relative change in tumor size on follow-up CT after 3 months (reduction ratio) were determined. Liver metastases were divided into two groups, responder and nonresponder. The correlation between %ADC and reduction ratio was determined, and %ADC was compared between the two groups. Eleven patients successfully completed HAIC over the 3-month period; 48 metastatic lesions were evaluated. Positive correlations were observed for relative change between %minADC and reduction ratio (r = 0.709) and between %meanADC and reduction ratio (r = 0.536). Both %minADC and %meanADC were significantly greater in the responder group than in the nonresponder group. With the threshold determined as < 3.5%, the receiver-operating curve analysis showed higher sensitivity and specificity values for %minADC (100% and 92.6%, respectively) than for %meanADC (66.7% and 74.1%, respectively). In conclusion, the relative change in minimum ADC values on DWI may be useful for early detection of the response of liver metastases to HAIC with 5-FU.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Deriving the Intrahepatic Arteriovenous Shunt Rate from CT Images and Biochemical Data Instead of from Arterial Perfusion Scintigraphy in Hepatic Arterial Infusion Chemotherapy

The purpose of the present study was to elucidate a method for predicting the intrahepatic arteriovenous shunt rate from computed tomography (CT) images and biochemical data, instead of from arterial perfusion scintigraphy, because adverse exacerbated systemic effects may be induced in cases where a high shunt rate exists. CT and arterial perfusion scintigraphy were performed in patients with liver metastases from gastric or colorectal cancer. Biochemical data and tumor marker levels of 33 enrolled patients were measured. The results were statistically verified by multiple regression analysis. The total metastatic hepatic tumor volume (V{sub metastasized}), residual hepatic parenchyma volume (V{sub residual}; calculated from CT images), and biochemical data were treated as independent variables; the intrahepatic arteriovenous (IHAV) shunt rate (calculated from scintigraphy) was treated as a dependent variable. The IHAV shunt rate was 15.1 {+-} 11.9%. Based on the correlation matrixes, the best correlation coefficient of 0.84 was established between the IHAV shunt rate and V{sub metastasized} (p < 0.01). In the multiple regression analysis with the IHAV shunt rate as the dependent variable, the coefficient of determination (R{sup 2}) was 0.75, which was significant at the 0.1% level with two significant independent variables (V{sub metastasized} and V{sub residual}). The standardized regression coefficients ({beta}) of V{sub metastasized} and V{sub residual} were significant at the 0.1 and 5% levels, respectively. Based on this result, we can obtain a predicted value of IHAV shunt rate (p < 0.001) using CT images. When a high shunt rate was predicted, beneficial and consistent clinical monitoring can be initiated in, for example, hepatic arterial infusion chemotherapy.

62 RADIOLOGY AND NUCLEAR MEDICINE↗